Marker Therapeutics, Inc.

Tagged: london pharma

TapImmune Appoints David Laskow-Pooley, CEO of London Pharma, to its Board of Directors

…SEATTLE, March 19, 2015 – TapImmune Inc. (OTCBB: TPIV) is pleased to announce the appointment of David Laskow-Pooley to the Company’s Board of Directors.

David brings 30 years of experience in all aspects of the discovery, development and commercialization of pharmaceutical and healthcare products. He has a successful track record of building, developing, operating and exiting start-up businesses, spin-outs from large corporations and business entities within large companies.

Read More